The Gorlin Syndrome Group is following the recommendations of the UK government regarding COVID-19 (coronavirus). Individuals with Gorlin syndrome, in general, are not considered at greater risk for this virus. There are exceptions, these include being of advanced age, or having underlying health issues such as diabetes, heart and lung disease.
For those on hedgehog inhibitors (Odomzo and Erivedge for the treatment of BCCs) it is worth noting that manufactures of the drugs have confirmed that these medications are not immune-suppressants.
For any individual concerns about your health it is advisable to contact your health care provider.
For more guidance visit https://www.gov.uk/government/collections/coronavirus-covid-19-list-of-guidance